157 related articles for article (PubMed ID: 28646641)
1. Do large mergers increase or decrease the productivity of pharmaceutical R&D?
Ringel MS; Choy MK
Drug Discov Today; 2017 Dec; 22(12):1749-1753. PubMed ID: 28646641
[TBL] [Abstract][Full Text] [Related]
2. Mergers and innovation in the pharmaceutical industry.
Comanor WS; Scherer FM
J Health Econ; 2013 Jan; 32(1):106-13. PubMed ID: 23220457
[TBL] [Abstract][Full Text] [Related]
3. A lesson from Japan: research and development efficiency is a key element of pharmaceutical industry consolidation process.
Shimura H; Masuda S; Kimura H
Drug Discov Ther; 2014 Feb; 8(1):57-63. PubMed ID: 24647159
[TBL] [Abstract][Full Text] [Related]
4. Organizational effectiveness: a key to R&D productivity.
Tollman P; Panier V; Dosik D; Biondi P; Cuss F
Nat Rev Drug Discov; 2016 Jul; 15(7):441-2. PubMed ID: 27312725
[TBL] [Abstract][Full Text] [Related]
5. Research and development productivity map: visualization of industry status.
Shimura H; Masuda S; Kimura H
J Clin Pharm Ther; 2014 Apr; 39(2):175-80. PubMed ID: 24438433
[TBL] [Abstract][Full Text] [Related]
6. An assessment of R&D productivity in the pharmaceutical industry.
Dimitri N
Trends Pharmacol Sci; 2011 Dec; 32(12):683-5. PubMed ID: 22030299
[TBL] [Abstract][Full Text] [Related]
7. The development speed paradox: can increasing development speed reduce R&D productivity?
Lendrem DW; Lendrem BC
Drug Discov Today; 2014 Mar; 19(3):209-14. PubMed ID: 24051396
[TBL] [Abstract][Full Text] [Related]
8. Design principles for innovative workspaces to increase efficiency in pharmaceutical R&D: lessons learned from the Novartis campus.
Zoller FA; Boutellier R
Drug Discov Today; 2013 Apr; 18(7-8):318-22. PubMed ID: 23318251
[TBL] [Abstract][Full Text] [Related]
9. Patient-centered drug discovery as the means to improved R&D productivity.
Raoof AA; Aerssens J
Drug Discov Today; 2015 Sep; 20(9):1044-8. PubMed ID: 25908579
[No Abstract] [Full Text] [Related]
10. The genetics of a pharma merger.
Sanseau P; Chabot-Fletcher M; Browne MJ
Drug Discov Today; 2009 Apr; 14(7-8):334-6. PubMed ID: 19121408
[TBL] [Abstract][Full Text] [Related]
11. Racing to define pharmaceutical R&D external innovation models.
Wang L; Plump A; Ringel M
Drug Discov Today; 2015 Mar; 20(3):361-70. PubMed ID: 25448753
[TBL] [Abstract][Full Text] [Related]
12. Open-access public-private partnerships to enable drug discovery--new approaches.
Müller S; Weigelt J
IDrugs; 2010 Mar; 13(3):175-80. PubMed ID: 20191434
[TBL] [Abstract][Full Text] [Related]
13. Measuring the efficiency of large pharmaceutical companies: an industry analysis.
Gascón F; Lozano J; Ponte B; de la Fuente D
Eur J Health Econ; 2017 Jun; 18(5):587-608. PubMed ID: 27344446
[TBL] [Abstract][Full Text] [Related]
14. Can emerging drug classes improve R&D productivity?
Meier C; Cairns-Smith S; Schulze U
Drug Discov Today; 2013 Jul; 18(13-14):607-9. PubMed ID: 23702084
[No Abstract] [Full Text] [Related]
15. The paradox of scientific excellence and the search for productivity in pharmaceutical research and development.
Grasela TH; Slusser R
Clin Pharmacol Ther; 2014 May; 95(5):521-7. PubMed ID: 24458012
[TBL] [Abstract][Full Text] [Related]
16. The impact of mergers on pharmaceutical R&D.
LaMattina JL
Nat Rev Drug Discov; 2011 Aug; 10(8):559-60. PubMed ID: 21804580
[TBL] [Abstract][Full Text] [Related]
17. Torching the Haystack: modelling fast-fail strategies in drug development.
Lendrem DW; Lendrem BC
Drug Discov Today; 2013 Apr; 18(7-8):331-6. PubMed ID: 23246516
[TBL] [Abstract][Full Text] [Related]
18. Improving R&D productivity of pharmaceutical companies through public-private partnership: experiences from the Innovative Medicines Initiative.
Laverty H; Gunn M; Goldman M
Expert Rev Pharmacoecon Outcomes Res; 2012 Oct; 12(5):545-8. PubMed ID: 23136843
[No Abstract] [Full Text] [Related]
19. Accessing external innovation in drug discovery and development.
Tufféry P
Expert Opin Drug Discov; 2015 Jun; 10(6):579-89. PubMed ID: 25910932
[TBL] [Abstract][Full Text] [Related]
20. Leveraging Industry-Academia Collaborations in Adaptive Biomedical Innovation.
Stewart SR; Barone PW; Bellisario A; Cooney CL; Sharp PA; Sinskey AJ; Natesan S; Springs SL
Clin Pharmacol Ther; 2016 Dec; 100(6):647-653. PubMed ID: 27617845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
